Lupin’s ESG score rises to 76 in S&P Global ESG Ratings November 26, 2024 Global pharma major Lupin Limited (Lupin) today announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector. The company has demonstrated... Trending Post-Covid spike in auto-immune disorders like Rheumatoid Arthritis: Experts Gear up health infra preparation for Heat wave: Centre writes to states, UTs Again, epilepsy drug from Delhi hospitals failed test Latest ‘Insurance Reforms, Public Financing & Workplace Fertility Benefits must for infertility care in India’ AIIMS Doctor perform congenital lung malformation rare surgery on 4-month child 29-year-old woman undergoes breast reconstruction for childhood burn deformity Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test
